期刊文献+

Pathophysiology and biology of peritoneal carcinomatosis 被引量:8

Pathophysiology and biology of peritoneal carcinomatosis
下载PDF
导出
摘要 Peritoneal carcinomatosis represents a devastating form of cancer progression with a very poor prognosis.Its complex pathogenesis is represented by a dynamic process comprising several steps.To the best of our knowledge pathogenesis can be partly explained by 3 major molecular pathways: (1) dissemination from the primary tumor;(2) primary tumor of peritoneum;and (3) independent origins of the primary tumor and peritoneal implants.These are not mutually exclusive and combinations of different mechanisms could occur inside a single case.There are still several aspects which need explanation by future studies.A comprehensive understanding of molecular events involved in peritoneal carcinomatosis is of paramount importance and should be systematically pursued not only to identify novel strategies for the prevention of the condition,but also to obtain therapeutic advances,through the identification of surrogate markers of prognosis and development of future molecular targeted therapies. Peritoneal carcinomatosis represents a devastating form of cancer progression with a very poor prognosis. Its complex pathogenesis is represented by a dynamic process comprising several steps. To the best of our knowledge pathogenesis can be partly explained by 3 major molecular pathways: (1) dissemination from the primary tumor; (2) primary tumor of peritoneum; and (3) independent origins of the primary tumor and peritoneal implants. These are not mutually exclusive and combinations of different mechanisms could occur inside a single case. There are still several aspects which need explanation by future studies. A comprehensive understanding of molecular events involved in peritoneal carcinomatosis is of paramount importance and should be systematically pursued not only to identify novel strategies for the prevention of the condition, but also to obtain therapeutic advances, through the identification of surrogate markers of prognosis and development of future molecular targeted therapies.
出处 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2010年第1期12-18,共7页 世界胃肠肿瘤学杂志(英文版)(电子版)
关键词 PATHOPHYSIOLOGY PERITONEAL CARCINOMATOSIS PERITONEAL MESOTHELIOMA PSEUDOMYXOMA peritonei Ovarian CANCER Gastric and colorectal CANCER Pathophysiology Peritoneal carcinomatosis Peritoneal mesothelioma Pseudomyxoma peritonei Ovarian cancer Gastric and colorectal cancer
  • 相关文献

参考文献48

  • 1Elizabeth M. Murphy Ph.D.,Rosemary Sexton B.Sc.,Brendan J. Moran M.Ch..Early Results of Surgery in 123 Patients with Pseudomyxoma Peritonei from a Perforated Appendiceal Neoplasm[J]. Diseases of the Colon & Rectum . 2007 (1)
  • 2Dr. Marc Pocard M.D., Ph.D.,Philip Debruyne M.D.,Rui Bras-Gon?alves Ph.D.,Marc Mareel M.D., Ph.D.,Bernard Dutrillaux M.D., Ph.D.,Marie-France Poupon M.D., Ph.D..Single alteration ofp53 or E-cadherin genes can alter the surgical resection benefit in an experimental model of colon cancer[J]. Diseases of the Colon & Rectum . 2001 (8)
  • 3David G. Jayne,Ronan O’Leary,Andrew Gill,Adrian Hick,Pierre J. Guillou.A three-dimensional in-vitro model for the study of peritoneal tumour metastasis[J]. Clinical and Experimental Metastasis . 1999 (6)
  • 4Donald Hawes M.D.,Robert Robinson,Raymund Wira.Pseudomyxoma peritonei from metastatic colloid carcinoma of the breast[J]. Gastrointestinal Radiology . 1991 (1)
  • 5Goldie JH,,Coldman AJ,Ng V,Hopkins HA,Looney WB.A mathematical and computer-based model of alternating chemotherapy and radiation therapy in experimental neoplasms. Antibiotics and Chemotherapy . 1988
  • 6Yonemura Y,Endou Y,Nojima N,Kawamura T,Fujitia H,Kaji M,Ajisaka H,Bandou E,Sasaki T,Yamaguchi T,Harada S,Yamamoto H.A possible role of cytokines in the formation of peritoneal dissemination. International Journal of Oncology . 1997
  • 7Suzuki M,Kobayashi H,Tanaka Y,Hirashima Y,Kanayama N,Takei Y,Saga Y,Suzuki M,Itoh H,Terao T.Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin. International Journal of Cancer . 2003
  • 8Davies DE,,Farmer S,White J,Senior PV,Warnes SL,Alexander P.Contribution of host-derived growth factors to in vivo growth of a transplantable murine mammary carcinoma. British Journal of Cancer . 1994
  • 9Kahn MA,Demopoulos RI.Mucinous ovarian tumors with pseudomyxoma peritonei:a clinicopathological study. International Journal of Gynecological Pathology . 1992
  • 10Henzi T,Blum WV,Pfefferli M,Kawecki TJ,Salicio V,Schwaller B.SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis. American Journal of Pathology . 2009

共引文献6

同被引文献218

  • 1Li, Wen-Hua,Peng, Jun-Jie,Xiang, Jia-Qing,Chen, Wei,Cai, San-Jun,Zhang, Wen.Oncological outcome of unresectable lung metastases without extrapulmonary metastases in colorectal cancer[J].World Journal of Gastroenterology,2010,16(26):3318-3324. 被引量:12
  • 2Yutaka Yonemura,Ayman Elnemr,Yoshio Endou,Mitsumasa Hirano,Akiyoshi Mizumoto,Nobuyuki Takao,Masumi Ichinose,Masahiro Miura.Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer[J].World Journal of Gastrointestinal Oncology,2010,2(2):85-97. 被引量:28
  • 3Gaya Spolverato,Aslam Ejaz,Nilo Azad,Timothy M Pawlik.Surgery for colorectal liver metastases: The evolution of determining prognosis[J].World Journal of Gastrointestinal Oncology,2013,5(12):207-221. 被引量:7
  • 4Federico Coccolini,Federico Gheza,Marco Lotti,Salvatore Virzì,Domenico Iusco,Claudio Ghermandi,Rita Melotti,Gianluca Baiocchi,Stefano Maria Giulini,Luca Ansaloni,Fausto Catena.Peritoneal carcinomatosis[J].World Journal of Gastroenterology,2013,19(41):6979-6994. 被引量:9
  • 5季加孚.胃肠道恶性肿瘤外科的无瘤技术和原则[J].中国实用外科杂志,2005,25(4):254-256. 被引量:66
  • 6Dominique Elias,Fran?ois Quenet,Diane Goéré.Current Status and Future Directions in the Treatment of Peritoneal Dissemination from Colorectal Carcinoma[J]. Surgical Oncology Clinics of North America . 2012 (4)
  • 7C. William Helm.Current Status and Future Directions of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Ovarian Cancer[J]. Surgical Oncology Clinics of North America . 2012 (4)
  • 8Itzhak Avital,Bj?rn L.D.M. Brücher,Aviram Nissan,Alexander Stojadinovic.Randomized Clinical Trials for Colorectal Cancer Peritoneal Surface Malignancy[J]. Surgical Oncology Clinics of North America . 2012 (4)
  • 9Paul H. Sugarbaker.Early Intervention for Treatment and Prevention of Colorectal Carcinomatosis[J]. Surgical Oncology Clinics of North America . 2012 (4)
  • 10Guillaume Passot,Delphine Vaudoyer,Eddy Cotte,Benoit You,Sylvie Isaac,Fran?ois No?l Gilly,Faheez Mohamed,Olivier Glehen.Progression Following Neoadjuvant Systemic Chemotherapy May Not Be a Contraindication to a Curative Approach for Colorectal Carcinomatosis[J]. Annals of Surgery . 2012 (1)

引证文献8

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部